CLINICAL_TRIALS trial_result · 2010-06-16

Clinical Trial Update: Study of SAR97276A in the Treatment of Uncomplicated and Severe Malaria in Adults and Children. [Phase 2]

A Phase 2 study of SAR97276A for uncomplicated and severe malaria in adults and children was terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Sponsor: Sanofi | Conditions: Malaria | Phase 2 | Status: TERMINATED